NCT02187861 · Interventional trial
A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL)
Overall registry status Completed
Phase 2
Conditions Follicular Lymphoma
Delaware Valley sites
- University of Pennsylvania; School of Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory